This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 4.9% to $9.23 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 19,529.95 and the Dow Jones Industrial Average rising 1.0% to 42,762.87.
This was the stock's fourth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 85.1% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. rose 5.0% to $4.61, Fortress Biotech Inc. rose 6.4% to $2.00, and Viking Therapeutics Inc. rose 2.92% to $27.83.
Trading volume totaled 151,362, compared to the 50-day average of 153,733.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 06, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。